Key facts
- It has raised $11.2M; the latest was Seed Round ($8.6M) in Aug 2025.
- Notable investors include Eniac Ventures, Tau Ventures, Flare Capital Partners, Digital Health Venture Partners, Omega Healthcare Investors — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Cascala Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Cascala Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cascala Health
Developer of an integrated care transitions platform designed to help healthcare providers and patients bridge communication gaps between hospital discharge and post-acute care. The company's platform offers care navigation, medication management, proactive in-home care, transition event monitoring and patient engagement within post-acute care facilities, enabling patients to avoid hospital readmissions and promote long-term health in risk-based care models.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2024
- Employees
- 16
- Website
- cascalahealth.com/
- Ownership
- Privately Held (backing)
Cascala Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cascala Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cascala Health in its N-PORT filings yet. We sweep new filings monthly.